ACP Journal Club 2007: Vol 146 Index

2007·2.9 MB·English

AUTHOR INDEX 5
Bold type indicates authors of commentaries, editorials, letters, and Resource Corners; (No.) indicates issue number.
Abbruzzese JL, 2 Crowther M, 29 Havranek EP, 80
Adhikari N, 58 Cunningham D, 2 Haydel MJ, 42
Allenberg J, 33 Curhan GC, 22 Haynes B, 53
Allum WH, 2 Curtis SP, 44 Hayward AC, 61
Andersohn F, 75 Cutler JA, 16 Heart Protection Study Collaborative
Antonini A, 76 Cuzick J, 4 Group, 50
Appleton S, 18 Dagerman KS, 35 Henehan C, A-8—A-9 (No. 2)
Aschner P, 39 Darmon M, 69 Henry D, 24
Baerlocher MO, 23 Davis BR, 16 Herrera S, 51
Bagnardi V, 48 Day A, 62 Heyland D, 62
Baillie C, 64 De Lena M, 31 Hilden J, A-12 (No. 3)
Balk E, 59 de Morton N, 72 Hillegass WB, 49
Bandeira-Echtler E, 40 De Seigneux S, 14 Hillner BE, 4
Baron MA, 74 Dejager S, 74 Hirsch C, 34
Barter P, 30 Denman M, 44 Hlatky MA, 49
Bartle B, 77 Detar DT, 23 Ho PM, 47
Bates ER, 66—67 Detsky ME, 23 Hollingsworth JM, 22
Bax JJ, 20 Di Castelnuovo A, 48 Holroyd-Leduc J, 42
Bergerhoff K, 40 Dickersin K, A-8—A-9 (No. 1), A-11 (No. 2) Howard PA, 52
Beswick A, 80 Ding EL, 25 Howell A, 4
Beyssen B, 32 Dodek P, 62 Hylek E, 52
Bijker N, 3 Douillard JY, 31 Ilanne-Parikka P, 37
Bingisser R, 57 DouketisJ , 46 Isley WL, 10-11
Biondi-Zoccai GG, 58 Duffy M, 43
Jefts K, 72
Black DM, 64 Dunn A, 51 John O, 45
Blanc JJ, 41 Durga J, 71 Johnson BE, 65
Bogaisky M, 71 Ebrahim SH, 40, 80 Johnston SC, 79
Bohlius J, 6 Edmonds M, 21 Jones D, 5
Bosch J, 10 Edwards K, 11 Julian JA, 1
Bosch J, 8 Elliott WJ, 73 Juurlink D, 12
Bradley CP, 24 Ellis PM, 31 Kaatz S, 46
Briel M, 66 Ensrud KE, 64 Kashani A, 70
Brindle P, 80 Evans AT, 41 Katon WJ, 78
Bronson DL, 70 Evans CA, 45 Kaufman SR, 22
Brott BC, 49 Fahey T, 80 Kearon C, 1
Bruckmann H, 33 Fihn SD, 47 Keating J, 72
Brun-Buisson C, 62 Finckh A, 43 Khatcheressian J, 5
Brunner-La Rocca HP. 67 FitzGerald GA, 44 Kipnes MS, 39
Bryson CL, 47, 50 Foody JM, 70 Klarenbach S, 14
Bucher HC, 66 Frasure-Smith N, 68 Koszycki D, 68
Buckley NS, 17 Friedrich J, 58 aCroix AZ, 65
Buckley NS, 19 Gandhi GY, 8, 10-11 aine L, 13
Buser PT, 67 Garbe E, 75 andoni G, 58
Buzdar A, 4 Garcia D, 52 aRosa Ke s 30
Camus C, 15 Gatto G, 76 arson E, 35
Cannon CP, 44 Gerstein HC, 8, 10 au J, 38
Ceglia L, 38
Ghersi D, 5 autrette A, 69
Chan FKL, 13 Gill SS, 72 Lee S$, 53
Chang S, 9 Gilman RH, 45 Lee TA, 77
Chatellier G, 32 Ginsberg By] Leeuw PW, 59
Chen S, 53 Glasziou P, A-8—A-9, (No. 1), A-11 (No. 2) Legnani C, 29
Cheng E, 7 Goldman LE, 21 Leipzig RM, 71
Chessman AW, 23 Gonzalez EB, 77 I esperance FE, 68
Christ-Crain M, 57 Grab JD, 81 LeungJ , 43
Chua BH, 3 Graff MJ, 34 Leung WY, 9
Chung M, 59 Granger R, 36 Lin EH, 78
Clar C, 40 Granwehr B, 60 Linden W, 68
Combes A, 15 Gregor P, 12 Lindstrém J, 37
Cook D, 62 Grifoni S, 46 Lunceford JK, 39
Cook D, 69 Guyatt G, A-8-A-9, (No. 1), A-11 (No. 2) Magazzini S, 46
Cosmi B, 29 Hankey GJ, 79 Mahnken JD, 52
Costanzo S, 48 Harling R, 61 Martin J, A-10 (No. 1)
Craddock D, 11 Haverkamp W, 75 Mas Jl ’ 32
MAY/JUNE 2007 |V OLUME 146 * NUMBER 3
ACP JOURNAL CLUB
AUTHOR INDEX
Masoudi FA, 47 Quartieri F, 41 Spertus JA, 47
Massel D, 75-76 Raman G, 59 Stein ND, A-8-A-9 (No. 1), A-11 (No. 2)
McCall KL, 11 Ran ZH, 63 Stenning SP, 2
McCurry S, 35 Ranji SR, 21 Stolz D, 57
McDonald DR, 23 Reed SD, 65 Straus S, A-8—A-9 (No. 2), A-11 (No. 2), 42
McGeer A, 36 Richter B, 40 Stroupe KT, 49
McGettigan P, 24 Rifkin DE, 81 Suissa S, 75
Megarbane B, 69 Ringleb PA, 33 Sullivan EF, 37
Mehta RH, 81 Rocker G, 69 Suskin N, 75-76
Meijnen P, 3 Rogers MA, 22 Swiglo BA, 8
Meyer PM, 73 Rosell R, 31 Szmitko PE, 12
Mills D, 74 Rosenstock J, 74 Tariot PN, 35
Moayyedi P, 63 Rothwell PM, 79 Terespolsky D, 53
Molony DA, 25 Rotthoff JR, 60 The SPARCL Investigators, 7
Montori VM, 74 Roy A, 17 Thijssen M, 34
Moore DA, 45 Rudd P, 16 Thorpe KE, 42
Morrison DA, 49 Sackett DL, 32-33 Tonelli M, 15
Muscedere J, 62 Sacks HS, 61 Tong JL, 63
Newton KM, 65 Salpeter EEF, 17, 19 Trujillo-Santos J, 51
Neuyen-Huynh MN, 79 Salpeter SR, 12, 17, 19 Tsuyuki RT, 9
Niederberger M, 14 Sarnak MJ, 81 Tumlin JA, 58
Niewoehner DE, 57 Saudan P, 14 van Boxtel MP. 71
Nordmann AJ, 66 Schade R, 75 van Dijk N, 41
O’Brien SM, 81 Schneider ANE 35 Vanni S, 46
O’Malley PG, 30, 78 Schouten EG, 71 Vernooij-Dassen MJ, 34
Oczkowski W, 32-33 Schouten O, 20 Victor JC, 60
Ohmit SE, 60 Schwartz AV, 64 Vinsonneau C, 15
OrmistoTnM, 12, 17 Schweizer A, 74 Walters +B 36
Padwal R, 73 Scott IA, 20, A-8-A-11 (No. 3) Wang W, 53
Page MA, 51 Seidenfeld J, 6 Waters DD, 30
Palareti G, 29 Shafazand S, 18-19 Weiss KB, 77
Pannu N, 14, 15 Shah NR, A-11 (No. 1) Welborn J, 6
Peltonen M, 37 Shekelle P, 48 Werten S, 61
Perera R, A-8—A-9 (No. 2) Shen J, 63 White RH, 1
Peterse JL, 3 Shireman TI, 52 Wilcken N, 5
Pfisterer M, 67 Shojania KG, 21 Wilson J, 6
Phillips CO, 70 Simel DL, 21 Wu JY, 9
Piller LB, 16 Simon GE, 78 Xiao SD, 63
Pittas AG, 38 Smith B, 18 YusufS , 8, 10
Pitts SR, 43 Smith BJ, 17 Zanettini R, 76
Poldermans D, 20 Smith D, 40 Zhang CX, 63
Poole Py, 18, 36 Smith TJ, 5 Zhang J, 25
Pugh JA, 39 Song Y, 25
Punthakee Z, 38 Sotos JG, A-10 (No. 2)
MaAyY/JUNE 2007 |V OLUME 146 © NUMBER 3
ACP JOURNAL CLUB
UBJECT INDEX
A Review: ACE inhibitors and angiotensin-receptor blockers reduce
Abdomen, acute diabetes in hypertension and other CV risk factors, 11
Review: Opiate administration may alter physical examination Angiotensin-converting enzyme inhibitors
findings, but does not increase management errors in acute Ramipril did not reduce incident diabetes in patients with impaired
glycemic control, 10
abdominal pain, 21
Review: ACE inhibitors and angiotensin-receptor blockers reduce
Acute disease
diabetes in hypertension and other CV risk factors, 11
Review: Exercise interventions reduce length and cost of hospital
Antiasthmatic agents
stay in older patients hospitalized for acute conditions, 72
Review: Long-acting B-agonists increase severe asthma exacerbations
Adenocarcinoma
and asthma-related deaths in children and adults, 17
Perioperative chemotherapy improved survival in resectable
adenocarcinoma of the stomach or lower esophagus, 2 Antibacterial agents
Use of different diagnostic methods for ventilator-associated
Adrenergic O-antagonists
pneumonia did not affect mortality or targeted antibiotic use, 62
Review: Medical therapy with calcium-channel blockers or
Anticoagulants
a-blockers helps patients to pass urinary stones, 22
An abnormal D-dimer test result indicated that anticoagulation
Adrenergic B-agonists
should be continued, 29
Review: Anticholinergics, but not B,-agonists, reduce exacerbations
Fixed-dose, weight-adjusted, unfractionated heparin was as
requiring hospitalization and respiratory deaths in COPD, 19
Review: Long-acting §,-adrenoceptor agonists are effective in poorly effective and safe as low-molecular-weight heparin for venous
reversible chronic obstructive pulmonary disease, 18 thromboembolism, |
Review: Long-acting B-agonists increase severe asthma exacerbations A risk model predicted major bleeding in older patients with atrial
fibrillation receiving warfarin therapy, 52
and asthma-related deaths in children and adults, 17
Adrenergic B-antagonists Antihypertensive agents
Discontinuation of medications 1 month after an acute myocardial Review: Angiotensin-receptor blockers and angiotensin-converting
enzyme inhibitors have the lowest risk for diabetes, 73
infarction increased risk for death at 12 months, 47
No cardiac testing for intermediate-risk patients on B-blockers was Anti-inflammatory agents, nonsteroidal
Etoricoxib was noninferior to diclofenac for cardiovascular outcomes
noninferior to testing before vascular surgery for preventing
in osteoarthritis and rheumatoid arthritis, 44
death and nonfatal MI, 20
Nonsteroidal antiinflammatory drugs did not increase risk for
Albuterol
all-cause mortality in osteoarthritis, 77
Review: Long-acting B,-adrenoceptor agonists are effective in poorly
Review: Nonselective nonsteroidal anti-inflammatory drugs do not
reversible chronic obstructive pulmonary disease, 18
Alcohol drinking increase risk for cardiovascular events, 12
Review: Risk for cardiovascular events is increased with rofecoxib,
Review: High alcohol intake increases mortality in both men and
diclofenac, and indomethacin, but not celecoxib, 24
women, 48
Antineoplastic agents
Alendronate
Adjuvant vinorelbine plus cisplatin extended survival longer than
Continuing alendronate for an additional 5 years maintained bone
observation in resected non-small-cell lung cancer, 31
mineral density in postmenopausal women, 64
Anastrozole had a better risk—benefit profile than tamoxifen as
Alzheimer disease
adjuvant treatment for breast cancer in postmenopausal women, 4
Olanzapine, quetiapine, or risperidone did not differ from placebo
Perioperative chemotherapy improved survival in resectable
for Alzheimer disease, 35
adenocarcinoma of the stomach or lower esophagus, 2
Amlodipine
Review: Adding cytotoxic drugs to a chemotherapy regimen
Diuretics were superior to calcium-channel blockers and short-term
increases tumor response rates and toxicity, but not survival in
ACE inhibitors ior reducing heart failure in hypertension, 16
metastatic breast cancer, 5
Analgesics, opioid
Review: Opiate administration may alter physical examination Antipsychotic agents
findings, but does not increase management errors in acute Olanzapine, quetiapine, or risperidone did not differ from placebo
for Alzheimer disease, 35
abdominal pain, 21
Arrhythmia
Anemia
Review: Rofecoxib increases renal events and arrhythmia, but a
Review: Erythropoietin or darbepoetin for anemia in patients
COX-2-inhibitor class effect does not exist, 25
with cancer produces both benefits and harms with no increase
Arterial occlusive diseases
in survival, 6
Simvastatin was cost-effective across a broad range of risk and age
Angioplasty
Noninferiority was not shown between stenting and endarterectomy groups, 50
Arthritis, rheumatoid
in severe symptomatic carotid stenosis, 33
Etoricoxib was noninferior to diclofenac for cardiovascular outcomes
Urgent revascularization with PCI was more cost-effective than
in osteoarthritis and rheumatoid arthritis, 44
CABG in medically refractory, high-risk myocardial ischemia, 49
Aspirin
Angiotensin-receptor blockers Discontinuation of medications 1 month after an acute myocardial
Ramipril did not reduce incident diabetes in patients with impaired
infarction increased risk for death at 12 months, 47
glycemic control, 10
ACP JOURNAL CLUB MAY/JUNE 2007 |V OLUME 146 * NUMBER 3
SUBJECT INDEX
Review: Low-dose aspirin causes a small increase in gastrointestinal Cerebrovascular disorders
bleeding, 13 ABCD, California, and unified ABCD2 risk scores predicted stroke
Asthma within 2, 7, and 90 days after TIA, 79
Review: Long-acting f-agonists increase severe asthma exacerbations Atorvastatin at 80 mg/d reduced cerebrovascular events more than
and asthma-related deaths in children and adults, 17 atorvastatin at 10 mg/d in stable coronary heart disease, 30
Atrial fibrillation Atorvastatin reduced stroke and CV events after recent stroke or TIA
A risk model predicted major bleeding in older patients with atrial in patients with no known coronary heart disease, 7
fibrillation receiving warfarin therapy, 52 Cholesterol, LDL
Atorvastatin at 80 mg/d reduced cerebrovascular events more than
atorvastatin at 10 mg/d in stable coronary heart disease, 30
B
Cholinergic antagonists
Blood glucose Review: Anticholinergics, but not B,-agonists, reduce exacerbations
Sitagliptin improved glycemic control and B-cell function in type 2 requiring hospitalization and respiratory deaths in COPD, 19
diabetes, 39 Cimicifuga
Bone density Herbal supplements did not relieve vasomotor symptoms of
Continuing alendronate for an additional 5 years maintained bone menopause in women, 65
mineral density in postmenopausal women, 64 Citalopram
Breast neoplasms Citalopram reduced depressive symptoms in coronary artery disease
10-year follow-up showed benefit of adding radiotherapy to local with depression, 68
excision for ductal carcinoma in situ, 3 Colorectal neoplasms, hereditary nonpolyposis
Anastrozole had a better risk—benefit profile than tamoxifen as adjuvant The MMRpro model accurately predicted the probability of carrying
treatment for breast cancer in postmenopausal women, 4 a cancer-susceptibility gene mutation for the Lynch syndrome, 53
Review: Adding cytotoxic drugs to a chemotherapy regimen increases Coronary disorders
tumor response rates and toxicity, but not survival in metastatic Atorvastatin at 80 mg/d reduced cerebrovascular events more than
breast cancer, 5 atorvastatin at 10 mg/d in stable coronary heart disease, 30
Bronchoalveolar lavage Citalopram reduced depressive symptoms in coronary artery disease
Use of different diagnostic methods for ventilator-associated
with depression, 68
pneumonia did not affect mortality or targeted antibiotic use, 62
Drug-eluting stents increased risk for late cardiac deaths or
Bronchodilator agents
myocardial infarction more than bare-metal stents, 66
Review: Long-acting B.,-adrenoceptor agonists are effective in poorly
No cardiac testing for intermediate-risk patients on B-blockers was
reversible chronic obstructive pulmonary disease, 18 noninferior to testing before vascular surgery for preventing
death and nonfatal MI, 20
.& Nonsteroidal antiinflammatory drugs did not increase risk for
Calcium-channel blockers all-cause mortality in osteoarthritis, 77
Review: Medical therapy with calcium-channel blockers or ot-blockers Review: Drug-eluting stents for coronary artery disease do not
helps patients to pass urinary stones, 22 reduce mortality more than bare-metal stents, 66
Carcinoma Simvastatin was cost-effective across a broad range of risk and age
Adjuvant vinorelbine plus cisplatin extended survival longer than groups, 50
observation in resected non-small-cell lung cancer, 31 Urgent revascularization with PCI was more cost-effective than
10-year follow-up showed benefit of adding radiotherapy to local CABG in medically refractory, high-risk myocardial ischemia, 49
excision for ductal carcinoma in situ, 3 Critical pathways
Cardiac surgical procedures Correction: A nurse-led clinical pathway reduced hospitalizations in
A bedside tool predicted the need for dialysis after cardiac surgery, 81 nursing home residents with pneumonia, A-11 (No. 2)
Cardiovascular diseases A nurse-led clinical pathway reduced hospitalizations in nursing
Review: Framingham risk scores have variable accuracy in predicting home residents with pneumonia, 25
CVD events in different patient populations, 80 Cyclooxygenase-2 inhibitors
Review: Nonselective nonsteroidal anti-inflammatory drugs do not Etoricoxib was noninferior to diclofenac for cardiovascular outcomes
increase risk for cardiovascular events, 12 in osteoarthritis and rheumatoid arthritis, 44
Review: Risk for cardiovascular events is increased with rofecoxib, Review: Risk for cardiovascular events is increased with rofecoxib,
diclofenac, and indomethacin, but not celecoxib, 24 diclofenac, and indomethacin, but not celecoxib, 24
Carotid stenosis Review: Rofecoxib increases renal events and arrhythmia, but a
Noninferiority was not shown between stenting and endarterectomy COX-2-inhibitor class effect does not exist, 25
in severe symptomatic carotid stenosis, 33
Stenting led to more stroke or death than did endarterectomy in D
symptomatic carotid stenosis > 60%, 32
Catheterization, central venous Dementia
Ultrasonographic guidance increased successful insertion of internal Community-based occupational therapy improved daily functioning
jugular vein catheter in the emergency department, 43 in older patients with dementia, 34
MAY/JUNE 2007 | VOLUME 146 ¢ NUMBER 3 ACP JOURNAL CLUB
SUBJECT INDEX
Depression Pergolide and cabergoline were associated with increased risk for
Citalopram reduced depressive symptoms in coronary artery disease newly diagnosed cardiac-valve regurgitation, 75
with depression, 68 Erythropoietin
Collaborative care for depression in patients with diabetes increased Review: Erythropoietin or darbepoetin for anemia in patients with
depression-free days and had economic benefit, 78 cancer produces both benefits and harms with no increase in
Diabetes mellitus survival, 6
Collaborative care for depression in patients with diabetes increased
Esophageal neoplasms
depression-free days and had economic benefit, 78
Perioperative chemotherapy improved survival in resectable
How should clinicians interpret results reflecting the effect of an
adenocarcinoma of the stomach or lower esophagus, 2
intervention on composite endpoints?, A-12, (No. 3)
Estrogen replacement therapy
A lifestyle intervention continued to prevent type 2 diabetes in
Herbal supplements did not relieve vasomotor symptoms of
high-risk patients after the program was stopped, 37
Ramipril did not reduce incident diabetes in patients with impaired menopause, 65
Ethanolamines
glycemic control, 10
Review: ACE inhibitors and angiotensin-receptor blockers reduce Review: Long-acting B,-adrenoceptor agonists are effective in poorly
diabetes in hypertension and other CV risk factors, 1 1 reversible chronic obstructive pulmonary disease, 18
Review: Angiotensin-receptor blockers and angiotensin-converting Evidence-based medicine
enzyme inhibitors have the lowest risk for diabetes, 73 The evolving science of translating research evidence into clinical
Review: Inhaled insulin provides better glycemic control than oral practice, A-8 (No. 3)
hypoglycemic agents but not better than subcutaneous insulin, 38 Making sense of diagnostic test likelihood ratios, A-8—A-9 (No. 2)
Review: Pioglitazone does not reduce risk for mortality or cardiovascular Misunderstandings, misperceptions, and mistakes,
events in type 2 diabetes, 40 A-8—A-9 (No. 1)
Rosiglitazone reduced type 2 diabetes but increased heart failure in Resource Corner: Statistical Evidence in Medical Trials: What De the
patients with impaired glycemic control, 8 Data Really Tell Us?, A-10 (No. 1)
Simvastatin was cost-effective across a broad range of risk and age Simplified calculations using likelihood ratios, A-10 (No 2)
groups, 50 Exercise
Sitagliptin improved glycemic control and B-cell function in type 2
A lifestyle intervention continued to prevent type 2 diabetes in
diabetes, 39 high-risk patients after the program was stopped, 37
Vildagliptin was noninferior to rosiglitazone for glycemic control in
No cardiac testing for intermediate-risk patients on B-blockers was
type 2 diabetes but caused less weight gain, 74
noninferior to testing before vascular surgery for preventing
Dibenzothiazepines
death and nonfatal MI, 20
Olanzapine, quetiapine, or risperidone did not differ from placebo
Physical counterpressure maneuvers reduced vasovagal syncope, 41
for Alzheimer disease, 35
Review: Exercise interventions reduce length and cost of hospital
Diclofenac
Etoricoxib was noninferior to diclofenac for cardiovascular outcomes stay in older patients hospitalized for acute conditions, 72
in osteoarthritis and rheumatoid arthritis, 44
Diet
A lifestyle intervention continued to prevent type 2 diabetes in
high-risk patients after the program was stopped, 37 Fenoldopam
Dipeptidyl peptidases Review: Fenoldopam reduces acute kidney injury and death in critical
Sitagliptin improved glycemic control and B-cell function in type 2 illness, 58
diabetes, 39 Fibrin fibrinogen degradation products
Disease transmission, professional-to-patient An abnormal D-dimer test result indicated that anticoagulation
Encouraging influenza vaccination for nursing home staff reduced should be continued, 29
mortality and influenza-like illness in the residents, 61 Fibrinolytic agents
Dopamine agonists A simple risk score discriminated between patients at low or high
Pergolide and cabergoline increased risk for valvular heart disease in risk for adverse events during therapy for acute DVT, 51
Parkinson's disease, 76 Folic acid
Pergolide and cabergoline were associated with increased risk for
Daily folic acid supplementation for 3 years improved cognitive
newly diagnosed cardiac-valve regurgitation, 75
function in older persons, 71
E Fractures, bone
Continuing alendronate for an additional 5 years maintained bone
Endarterectomy, carotid
mineral density in postmenopausal women, 64
Noninferiority was not shown between stenting and endarterectomy
in severe symptomatic carotid stenosis, 33
Stenting led to more stroke or death than did endarterectomy in G
symptomatic carotid stenosis 2 60%, 32
Genetic screening
Ergolines
Pergolide and cabergoline increased risk for valvular heart disease in The MMRpro model accurately predicted the probability of carrying a
Parkinson's disease, 76 cancer-susceptibility gene mutation for the Lynch syndrome, 53
ACP JOURNAL CLUB MAY/JUNE 2007 | VOLUME 146 * NUMBER 3
SUBJECT INDEX
H Review: Statin monotherapy is safe in hyperlipidemia except for
Headache increased risk for transaminase elevation, 70
Review: History and physical examination can accurately identify Simvastatin was cost-effective across a broad range of risk and age
migraine and the need for neuroimaging in patients with groups, 50
headache, 23 Hypertension
Health services Diuretics were superior to calcium-channel blockers and short-term
ACE inhibitors for reducing heart failure in hypertension, 16
Encouraging influenza vaccination for nursing home staff reduced
mortality and influenza-like illness in the residents, 61 Hypoglycemic agents
Heart disease How should clinicians interpret results reflecting the effect of an
Diuretics were superior to calcium-channel blockers and short-term intervention on composite endpoints?, A-12 (No. 3)
ACE inhibitors for reducing heart failure in hypertension, 16 Review: Inhaled insulin provides better glycemic control than oral
Pergolide and cabergoline increased risk for valvular heart disease in ’ hypoglycemic agents but not better than subcutaneous insulin, 38
Parkinson's disease, 76 Review: Pioglitazone does not reduce risk for mortality or
Pergolide and cabergoline were associated with increased risk for cardiovascular events in type 2 diabetes, 40
newly diagnosed cardiac-valve regurgitation, 75 Rosiglitazone reduced type 2 diabetes but increased heart failure in
Helicobacter pylori patients with impaired glycemic control, 8
Review: Eradication therapy supplemented by probiotics increased
eradication rates and reduced side effects in H. pylori infection, 63
Hemodiafiltration
Continuous venovenous hemodiafiltration and intermittent Influenza
hemodialysis did not differ for improving survival in acute renal Encouraging influenza vaccination for nursing home staff reduced
failure with multiorgan dysfunction, 15 mortality and influenza-like illness in the residents, 61
Continuous venovenous hemodiafiltration increased survival more Inactivated influenza vaccine prevented influenza in healthy adults, 60
than did continuous hemofiltration in acute renal failure, 14 Insulin
Hemorrhage How should clinicians interpret results reflecting the effect of an
Review: Low-dose aspirin causes a small increase in gastrointestinal intervention on composite endpoints?, A-12 (No. 3)
bleeding, 13 Review: Inhaled insulin provides better glycemic control than oral
A risk model predicted major bleeding in older patients with atrial hypoglycemic agents but not better than subcutaneous insulin, 38
fibrillation receiving warfarin therapy, 52 Ischemic attack, transient
A simple risk score discriminated between patients at low or high Atorvastatin reduced stroke and CV events after recent stroke or TIA
risk for adverse events during therapy for acute DVT, 51
in patients with no known coronary heart disease, 7
Heparin, low-molecular-weight
The ABCD, California, and unified ABCD2 risk scores predicted
Fixed-dose, weight-adjusted, unfractionated heparin was as
stroke within 2, 7, and 90 days after TIA, 79
effective and safe as low-molecular-weight heparin for venous
thromboembolism, 1
Heptanoic acids K
Atorvastatin at 80 mg/d reduced cerebrovascular events more than
atorvastatin at 10 mg/d in stable coronary heart disease, 30 Kidney failure
Atorvastatin reduced stroke and CV events after recent stroke or TIA \ bedside tool predicted the need for dialysis after cardiac surgery, 81
in patients with no known coronary heart disease, 7 Continuous venovenous hemodiafiltration and intermittent
Hospitalization hemodialysis did not differ for improving surv ival in acute renal
Correction: A nurse-led clinical pathway reduced hospitalizations in failure with multiorgan dysfunction, 15
nursing home residents with pneumonia, A-11 (No. 2) Continuous venovenous hemodiafiltration increased survival more
A nurse-led clinical pathway reduced hospitalizations in nursing than did continuous hemofiltration in acute renal failure, 14
home residents with pnemonia, 25 Review: Fenoldopam reduces acute kidney injury and death in critical
Encouraging influenza vaccination for nursing home staff reduced illness, 58
mortality and influenza-like illness in the residents, 61
Review: Exercise interventions reduce length and cost of hospital
stay in older patients hospitalized for acute conditions, 72
Review: Long-acting f-agonists increase severe asthma exacerbations Lisinopril
Diuretics were superior to calcium-channel blockers and short-term
and asthma-related deaths in children and adults, 17
ACE inhibitors for reducing heart failure in hypertension, 16
Hot flashes
Herbal supplements did not relieve vasomotor symptoms of Lung diseases
menopause, 65 \djuvant vinorelbine plus cisplatin extended survival longer than
Hydroxymethylglutaryl-CoA reductase inhibitors observation in resected non-small-cell lung cancer, 31
Atorvastatin reduced stroke and CV events after recent stroke or TIA Procalcitonin level—guided treatment reduced antibiotic use in
in patients with no known coronary heart disease, 7 exacerbations of COPD, 57
Discontinuation of medications 1 month after an acute myocardial Review: Long-acting B,-adrenoceptor agonists are effective in poorly
infarction increased risk for death at 12 months, 47 reversible chronic obstructive pulmonary disease, 18
MAY/JUNE 2007 |V OLUME 146 * NUMBER 3 ACP JOURNAL CLUB
SUBJECT INDEX
M Pergolide
Medical informatics Pergolide and cabergoline increased risk for valvular heart disease in
The evolving science of translating research evidence into clinical Parkinson's disease, 76
Pergolide and cabergoline were associated with increased risk for
practice, A-8 (No. 3)
newly diagnosed cardiac-valve regurgitation, 75
Meningitis, bacterial
Pharmaceutical services
Review: Success of lumbar puncture is enhanced by reinserting the
Periodic telephone counseling for polypharmacy improved
stylet before removing the needle, 42
compliance and reduced mortality, 9
Microbial sensitivity tests
Physical examination
Microscopic-observation drug-susceptibility assay was more se..sitive
Review: Opiate administration may alter physical examination
than standard tests for diagnosing tuberculosis, 45
findings, but does not increase management errors in acute
Mycobacterium tuberculosis
abdominal pain, 21
Microscopic-observation drug-susceptibility assay was more sensitive
Phytotherapy
than standard tests for diagnosing tuberculosis, 45
Herbal supplements did not relieve vasomotor symptoms of
Myocardial disorders
Discontinuation of medications | month after an acute myocardial menopause in women, 65
Platelet aggregation inhibitors
infarction increased risk for death at 12 months, 47
Drug-eluting stents increased risk for late cardiac death or
Myocardial ischemia
myocardial infarction more than bare-metal stents, 67
Urgent revascularization with PCI was more cost-effective than
Review: Drug-eluting stents for coronary artery disease do not
CABG in medically refractory, high-risk myocardial ischemia, 49
reduce mortality more than bare-metal stents, 66
Pneumonia
N Correction: A nurse-led clinical pathway reduced hospitalizations in
Neoplasms nursing home residents with pneumonias A-11 (No. 2)
Review: Erythropoietin or darbepoetin for anemia in patients with A nurse-led clinical pathway reduced hospitalizations in nusring
cancer produces both benefits and harms with no increase in home residents with pneumonia, 25
survival, 6 Review: Trials of injectable pneumococcal vaccines do not show
10-year follow-up showed benefit of adding radiotherapy to local effectiveness in chronic obstructive pulmonary disease, 36
excision for ductal carcinoma in situ, 3 Use of different diagnostic methods for ventilator-associated
Nitrites pneumonia did not affect mortality or targeted antibiotic use, 62
Anastrozole had a better risk—benefit profile than tamoxifen as adjuvant Postoperative complications
treatment for breast cancer in postmenopausal women, 4 Ultrasonographic guidance increased successful insertion of internal
Nursing homes jugular vein catheter in the emergency department, 43
Correction: A nurse-led clinical pathway reduced hospitalizations in Pregnancy outcome
nursing home residents with pneumonia, A-11 (No. 2) How should clinicians interpret results reflecting the effect of an
Encouraging influenza vaccination for nursing home staff reduced intervention on composite endpoints?, A-12 (No. 3)
mortality and influenza-like illness in the residents, 61 Prepaid health plans
A nurse-led clinical pathway reduced hospitalizations in nursing Collaborative care for depression in patients with diabetes increased
home residents with pneumonia, 25 depression-free days and had economic benefit, 78
Probiotics
Review: Eradication therapy supplemented by probiotics increased
O eradication rates and reduced side effects in H. pylori infection, 63
Occupational therapy Professional-family relations
Community-based occupational therapy improved daily functioning A communication strategy and brochure reduced the burden of
in older patients with dementia, 34 bereavement on relatives of patients dying in the intensive care
Osteoarthritis unit, 69
Etoricoxib was noninferior to diclofenac for cardiovascular outcomes Psychotherapy, brief
in osteoarthritis and rheumatoid arthritis, 44 Citalopram reduced depressive symptoms in coronary artery disease
Nonsteroidal antiinflammatory drugs did not increase risk for with depression, 68
all-cause mortality in osteoarthritis, 77 Pulmonary disease
Outcome assessment (health care) Fixed-dose, weight-adjusted, unfractionated heparin was as
How should clinicians interpret results reflecting the effect of an effective and safe as low-molecular-weight heparin for venous
intervention on composite endpoints?, A-12 (No. 3) thromboembolism, |
Persistent right ventricular dysfunction increased risk for recurrent
venous thromboembolism after acute pulmonary embolism, 4¢
P Review: Anticholinergics, but not B,-agonists, reduce exacerbations
Parkinson disease requiring hospitalization and respiratory deaths in COPD, 19
Pergolide and cabergoline increased risk for valvular heart disease in Review: Trials of injectable pneumococcal vaccines do not show
Parkinson's disease, 76 effectiveness in chronic obstructive pulmonary disease, 36
ACP JOURNAL CLUB MAY/JUNE 2007 | VOLUME 146 ¢ NUMBER 3
SUBJECT INDEX
A simple risk score discriminated between patients at low or high Stenting led to more stroke or death than did endarterectomy in
risk for adverse events during therapy for acute DVT, 51 symptomatic carotid stenosis 2 60%, 32
An abnormal D-dimer test result indicated that anticoagulation Stomach neoplasms
should be continued, 29 Perioperative chemotherapy improved survival in resectable
Pyridines adenocarcinoma of the stomach or lower esophagus, 2
Etoricoxib was noninferior to diclofenac for cardiovascular outcomes Stress disorders, posttraumatic
in osteoarthritis and rheumatoid arthritis, 44 A communication strategy and brochure reduced the burden of
Pyrroles bereavement on relatives of patients dying in the intensive care
Atorvastatin at 80 mg/d reduced cerebrovascular events more than unit, 69
atorvastatin at 10 mg/d in stable coronary heart disease, 30 Sulfones
Atorvastatin reduced stroke and CV events after recent stroke or TIA Etoricoxib was noninferior to diclofenac for cardiovascular outcomes
in patients with no known coronary heart disease, 7 in osteoarthritis and rheumatoid arthritis, 44
Syncope, vasovagal
R Physical counterpressure maneuvers reduced vasovagal syncope, 41
Receptor, serotonin, 5-HT2B
Pergolide and cabergoline increased risk for valvular heart disease in :
Parkinson's disease, 76 Tamoxifen
Pergolide and cabergoline were associated with increased risk for Anastrozole had a better risk—benefit profile than tamoxifen as adjuvant
newly diagnosed cardiac-valve regurgitation, 75 treatment for breast cancer in postmenopausal women, 4
Renal disease Thiazolidinediones
A bedside tool predicted the need for dialysis after cardiac surgery, 81
Review: Pioglitazone does not reduce risk for mortality or cardiovascular
Continuous venovenous hemodiafiltration and intermittent events in type 2 diabetes, 40
hemodialysis did not differ for improving survival in acute renal
Ticlopidine
failure with multiorgan dysfunction, 15
Drug-eluting stents increased risk for late cardiac death or myocardial
Continuous venovenous hemodiafiltration increased survival more
infarction more than bare-metal stents, 67
than did continuous hemofiltration in acute renal failure, 14
Triazoles
Review: Medical treatment and revascularization may be similar in
Anastrozole had a better risk—benefit profile than tamoxifen as adjuvant
atherosclerotic renal artery stenosis, 59
treatment for breast cancer in postmenopausal women, 4
Review: Rofecoxib increases renal events and arrhythmia, but a
Tuberculosis
COX-2-inhibitor class effect does not exist, 25
Microscopic-observation drug-susceptibility assay was more sensitive
Risperidone
than standard tests for diagnosing tuberculosis, 45
Olanzapine, quetiapine, or risperidone did not differ from placebo
for Alzheimer disease, 35
Rosiglitazone U
Vildagliptin was noninferior to rosiglitazone for glycemic control in
Ultrasonography, interventional
type 2 diabetes but caused less weight gain, 74
Ultrasonographic guidance increased successful insertion of internal
jugular vein catheter in the emergency department, 43
Urinary calculi
Simvastatin Review: Medical therapy with calcium-channel blockers or &-blockers
Simvastatin was cost-effective across a broad range of risk and age helps patients to pass urinary stones, 22
groups, 50
Spinal puncture
V
Review: Success of lumbar puncture is enhanced by reinserting the
stylet before removing the needle, 42 Vasomotor system
Sputum Herbal supplements did not relieve vasomotor symptoms of
Microscopic-observation drug-susceptibility assay was more sensitive menopause in women, 65
than standard tests for diagnosing tuberculosis, 45 Venous thrombosis
Statistics An abnormal D-dimer test result indicated that anticoagulation
How should clinicians interpret results reflecting the effect of an should be continued, 29
intervention on composite endpoints?, A-12 (No. 3) Fixed-dose, weight-adjusted, unfractionated heparin was as
Stents effective and safe as low-molecular-weight heparin for venous
Drug-eluting stents increased risk for late cardiac death or myocardial thromboembolism, 1
infarction more than bare-metal stents, 67 A simple risk score discriminated between patients at low or high
Noninferiority was not shown between stenting and endarterectomy risk for adverse events during therapy for acute DVT, 51
in severe symptomatic carotid stenosis, 33 Ventricular dysfunction, right
Review: Drug-eluting stents for coronary artery disease do not Persistent right ventricular dysfunction increased risk for recurrent
reduce mortality more than bare-metal stents, 66 venous thromboembolism after acute pulmonary embolism, 46
MAY/JUNE 2007 |V OLUME 146 * NUMBER 3 ACP JOURNAL CLUB